Bilkent University National Nanotechnology Research Center’s (UNAM) Dr. Gürkan Yeşilöz has been awarded support from the Health Institute of Turkey (TÜSEB) as part of the institute’s aim to foster the research, development and commercialization of cancer treatment products using domestic resources. Dr. Yeşilöz’s goal is to engineer and introduce an innovative cancer treatment approach using nano drug carriers. This ongoing research and development endeavor represents a promising alternative in cancer therapy, as it seeks to enhance the efficacy of drugs by directly targeting cancer cells while mitigating adverse side effects.
Most Viewed
A Colorful Student Life
75 viewsAcademic Administrative Appointments
66 viewsA Day At Bilkent
60 views